BioCentury
ARTICLE | Clinical News

Indacaterol inflammation data

September 26, 2005 7:00 AM UTC

In a double-blind, dose-escalation trial in 24 patients, indacaterol was well tolerated with no adverse events and obvious dose relationship. Mean potassium and glucose levels and pulse rates were sim...